Stereotactic Radiation Therapy in Treating Patients With Brain Metastases

Completed · Not applicable

Conditions studied: Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase II trial is study how well stereotactic radiation therapy works in treating patients with brain metastases

Key facts

Study ID

NCT00983359

Run by

Ohio State University Comprehensive Cancer Center

People needed

40

Starts

2007-04-01

Expected to finish

2012-08-01

Last updated by the study team

2017-06-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histology-confirmed cancer with 1 to 3 symptomatic brain metastases imaged by MRI/CT scans.
• Have cancer not originating in central nervous system (CNS)
• Karnofsky score of at least 60
• Given written consent
• At least 18 years of age

You may not qualify if…

• Prior whole brain radiotherapy or prior focal radiotherapy of the metastasis/es considered for this trial.
• Certain radiosensitive primary tumors such as small cell lung cancer, germ cell tumors, lymphoma, leukemia or multiple myeloma.

Where it is running

• Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.